Should a Patient with Moderate Aortic Stenosis Be Referred to Cardiology?
Yes, cardiology referral is recommended for patients with moderate aortic stenosis to establish appropriate surveillance protocols and risk stratification, even though immediate intervention is typically not indicated.
Rationale for Referral
Moderate aortic stenosis (AS) requires specialized cardiovascular evaluation for several critical reasons:
Establishing Accurate Diagnosis and Surveillance
Patients with moderate AS need echocardiographic confirmation and grading, as discordant measurements between aortic valve area (1.0-1.5 cm²) and mean gradient (20-40 mmHg) can occur 1. Cardiology referral ensures proper diagnostic workup and establishes a surveillance schedule, which guidelines recommend at yearly intervals for moderate AS 1, 2. This is essential because AS progression is highly variable among individuals, and some patients may progress to severe disease requiring intervention 3.
Risk Stratification and Monitoring for Progression
The natural history of moderate AS is not as benign as previously thought. Recent evidence shows that moderate AS is associated with increased cardiovascular events and mortality 4, 5. Cardiologists can implement multimodality imaging approaches to evaluate left ventricular remodeling and identify high-risk features that may warrant closer follow-up or earlier intervention 4.
Key monitoring parameters include:
- Rate of peak velocity progression (≥0.3 m/s/year indicates higher risk) 6
- Development of left ventricular dysfunction
- Presence of moderate-to-severe valve calcification 6
- Exercise tolerance and symptom development
Special Clinical Scenarios Requiring Cardiology Input
Cardiology consultation is particularly important when:
Concurrent cardiac procedures are planned: Patients with moderate AS undergoing coronary artery bypass surgery or surgery of the ascending aorta or another valve should be considered for additional valve replacement 6, 3
Preoperative evaluation for non-cardiac surgery: Moderate AS patients require careful perioperative risk assessment, especially for high-risk surgical procedures 7, 8
Symptom assessment: Determining whether symptoms (dyspnea, exercise intolerance, syncope) are attributable to moderate AS versus other comorbidities requires specialized evaluation 9
Discordant grading: When valve area and gradient measurements don't align, advanced imaging and hemodynamic assessment by cardiology is needed 4, 10
Practical Management Algorithm
Initial referral to cardiology should occur at diagnosis of moderate AS to:
- Confirm severity with comprehensive echocardiography
- Establish baseline left ventricular function and dimensions
- Determine appropriate surveillance intervals (typically yearly) 1
- Educate patient about symptom recognition and when to report changes 9
- Assess for concurrent coronary artery disease or other valve pathology
- Consider exercise testing in select patients to unmask symptoms 2
Ongoing management involves:
- Annual echocardiographic surveillance 1, 2
- Prompt re-evaluation if symptoms develop
- Consideration of more frequent monitoring (6-12 months) if rapid progression is detected
- Management of concurrent cardiovascular risk factors (hypertension, hyperlipidemia) 9
Common Pitfalls to Avoid
Do not assume moderate AS is always stable or low-risk. Some patients progress rapidly, and recent data suggest moderate AS carries higher morbidity than previously recognized 4, 5. The traditional "watchful waiting" approach must be balanced with proactive surveillance.
Do not delay referral until symptoms develop. Establishing a cardiology relationship early allows for appropriate monitoring schedules and ensures patients understand warning symptoms that require urgent evaluation 9.
Do not overlook the need for re-evaluation before non-cardiac surgery. Moderate AS increases perioperative risk, and cardiology input is valuable for risk stratification and perioperative management planning 7, 8.
While immediate intervention is rarely indicated for moderate AS, cardiology referral establishes the framework for appropriate long-term management, timely detection of progression, and optimal timing of intervention when disease advances to severe stages 9, 11.